Inventor · disambiguated record
Lijuan Tang
Also filed as: TANG LIJUAN
8 granted patents·15 pending applications·148 citations·filing 2004–2025
88Inventor score
Files withALPHARMA PHARMACEUTICALS LLC12MATTHEWS FRANK4LIANG ALFRED2SHENZHEN CHINA STAR OPTOELECT2CHINESE INSTITUTE FOR BRAIN RES BEIJING1
Top patents by PatentIndex Score
23 records- 0196US7682633B2Pharmaceutical compositionALPHARMA PHARMACEUTICALS LLC·Filed 2009·Granted Mar 23, 2010·80 cites·10 claims
- 0293US7682634B2Pharmaceutical compositionsALPHARMA PHARMACEUTICALS LLC·Filed 2009·Granted Mar 23, 2010·24 cites·10 claims
- 0391US8623418B2Pharmaceutical compositionLIANG ALFRED·Filed 2008·Granted Jan 7, 2014·19 cites·14 claims
- 0488US8158156B2Abuse-deterrent multi-layer pharmaceutical composition comprising an opioid antagonist and an opioid agonistMATTHEWS FRANK·Filed 2007·Granted Apr 17, 2012·10 cites·65 claims
- 0587US8877247B2Abuse-deterrent multi-layer pharmaceutical composition comprising an opioid antagonist and an opioid agonistMATTHEWS FRANK·Filed 2010·Granted Nov 4, 2014·9 cites·16 claims
- 0685US8846104B2Pharmaceutical compositions for the deterrence and/or prevention of abuseMATTHEWS FRANK·Filed 2012·Granted Sep 30, 2014·6 cites·8 claims
- 0771US2010151014A1Pharmaceutical compositionALPHARMA PHARMACEUTICALS LLC·Filed 2008·Application pending·0 cites
- 0865US2019314289A1Pharmaceutical Compositions for the Deterrence and/or Prevention of AbuseALPHARMA PHARMACEUTICALS LLC·Filed 2018·Application pending·0 cites
- 0965US2014056975A1Pharmaceutical CompositionALPHARMA PHARMACEUTICALS LLC·Filed 2013·Application pending·0 cites
- 1065US2015024058A1Pharmaceutical Compositions for the Deterrence and/or Prevention of AbuseALPHARMA PHARMACEUTICALS LLC·Filed 2014·Application pending·0 cites
- 1162US2015104519A1Pharmaceutical CompositionsALPHARMA PHARMACEUTICALS LLC·Filed 2014·Application pending·0 cites
- 1260US2016375011A1Pharmaceutical CompositionALPHARMA PHARMACEUTICALS LLC·Filed 2016·Application pending·0 cites
- 1360US2017056329A1Pharmaceutical Compositions for the Deterrence and/or Prevention of AbuseALPHARMA PHARMACEUTICALS LLC·Filed 2016·Application pending·0 cites
- 1459US2012189705A1Pharmaceutical CompositionsMATTHEWS FRANK·Filed 2012·Application pending·0 cites
- 1559US2012121667A1Pharmaceutical CompositionLIANG ALFRED·Filed 2012·Application pending·0 cites
- 1658US2016058755A1Pharmaceutical CompositionALPHARMA PHARMACEUTICALS LLC·Filed 2015·Application pending·0 cites
- 1756US2014037721A1Pharmaceutical CompositionALPHARMA PHARMACEUTICALS LLC·Filed 2013·Application pending·0 cites
- 1855US2013122065A1Pharmaceutical CompositionALPHARMA PHARMACEUTICALS LLC·Filed 2013·Application pending·0 cites
- 1955US2005142193A1Galantamine formulationsFiled 2004·Application pending·0 cites
- 2051US11881589B2Battery module and battery pack having same for vehicleSVOLT ENERGY TECH CO LTD·Filed 2020·Granted Jan 23, 2024·0 cites·19 claims
- 2151US2025314868A1Curved light-sheet microscopic imaging device and methodCHINESE INSTITUTE FOR BRAIN RES BEIJING·Filed 2025·Application pending·0 cites
- 2233US9490124B2Polycrystalline silicon substrate and manufacturing method thereofSHENZHEN CHINA STAR OPTOELECT·Filed 2015·Granted Nov 8, 2016·0 cites·18 claims
- 2332US2016189990A1Laser crystallziation system and method of controlling crystallization energy thereinSHENZHEN CHINA STAR OPTOELECT·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lijuan Tang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →